Cancer searching after unprovoked Thromboembolism – still a clinical controversy

Autores

  • Joana Mendonça Hospital Senhora da Oliveira, Guimarães
  • Ana Luísa Campos Hospital Senhora da Oliveira, Guimarães
  • João Barbosa Martins Hospital Senhora da Oliveira, Guimarães
  • Ana Barbosa Hospital Senhora da Oliveira, Guimarães
  • Ana Sofia Rolo Hospital Senhora da Oliveira, Guimarães
  • Liliana Oliveira Hospital Senhora da Oliveira, Guimarães
  • Carolina Carvalho Hospital Senhora da Oliveira, Guimarães
  • Ilda Faustino
  • Alexandra Teixeira Hospital Senhora da Oliveira, Guimarães
  • Amilcar Mesquita Hospital Senhora da Oliveira, Guimarães
  • Camila Coutinho Hospital Senhora da Oliveira, Guimarães

Resumo

Introduction: Several trials failed to demonstrate the benefits of extensive
screening for the diagnosis of cancer after unprovoked venous thromboembolism
(VTE). The RIETE investigators recently proposed a score aimed to identify a subgroup
of patients at higher risk of occult cancer in this setting, that would benefit
from more extensive workup.
Methods: We performed a prospective and observational clinical study, that
aimed to validate the RIETE score in patients with unprovoked VTE. We calculated
the RIETE score to all patients, and the high-risk patients performed a CT
scan of the thorax, abdomen and pelvis, an upper gastrointestinal endoscopy and
a colonoscopy. All patients had clinical visits every three months for one year.
Results: We included 34 patients between November 2020 and April 2022.
Eight patients (23,5%) had a high-risk RIETE score. After a median follow-up of
21 months no cancer diagnosis was found.
Discussion and Conclusion: These results do not allow us to conclude about
the RIETE score power to distinguish high from low-risk patients of having a cancer
diagnosis after VTE, and further research is needed.
Key-words: Thromboembolism; cancer; RIETE score.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

R. Ihaddadene, D.J. Corsi, A. Lazo-Langner, et al., Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism, Blood 127 (16) (2016) 2035–2037, https://doi.org/10.1182/blood-2015-11-682963

N. van Es, C. Ay, L. Jara-Palomares, Screening for occult cancer in patients with venous thromboembolism: past, present, and future, Hamostaseologie 40 (3) (2020) 270–279, https://doi.org/10.1055/a-1150-2286

A. Piccioli, A.W.A. Lensing, M.H. Prins, et al., Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial, J. Thromb. Haemost. 2 (6) (2004) 884–889, https://doi.org/10.1111/j.1538-7836.2004.00720.x

M. Carrier, A. Lazo-Langner, S. Shivakumar, et al., Screening for occult cancer in unprovoked venous thromboembolism, N. Engl. J. Med. 373 (8) (2015) 697–704, https://doi.org/10.1056/NEJMoa1506623

P. Robin, P.Y. Le Roux, B. Planquette, et al., Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial, The Lancet Oncology 17 (2) (2016) 193–199, https://doi.org/10.1016/S1470-2045(15) 00480-5

L. Jara-Palomares, R. Otero, D. Jimenez, et al., Development of a risk prediction score for occult cancer in patients with VTE, Chest 151 (3) (2017) 564–571, https://doi.org/10.1016/j.chest.2016.10.025

L. Jara-Palomares, R. Otero, D. Jimenez, et al., Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism, PLoS One 13 (3) (2018) 1–11, https://doi.org/10.1371/journal.pone.0194673

L. Bertoletti, P. Robin, L. Jara-Palomares, et al., Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score, J. Thromb. Haemost. 15 (11) (2017) 2184–2187, https://doi.org/10.1111/ jth.13842

A. Rosell, S. Lundstrom, N. Mackman, et al., A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism, J. Thromb. Thrombolysis 48 (1) (2019) 111–118, https://doi.org/ 10.1007/s11239-019-01822-z

J.C. Mendonça, J. Martins, C. Fernandes, et al., Cancer risk after a venous thrombotic event - RIETE score, Thrombosis Research 202 (2021) 43–44, https://doi.org/10.1016/j.thromres.2021.02.036

Downloads

Publicado

2024-06-26

Edição

Secção

Artigos de investigação original

Como Citar

Mendonça, J., Campos, A. L., Barbosa Martins, J., Barbosa, A., Rolo, A. S., Oliveira, L., Carvalho, C., Faustino, I., Teixeira, A., Mesquita, A., & Coutinho, C. (2024). Cancer searching after unprovoked Thromboembolism – still a clinical controversy. Revista Portuguesa de Oncologia, 7(1-2), 31-34. https://rponcologia.com/index.php/rpo/article/view/90

Artigos mais lidos do(s) mesmo(s) autor(es)